Karl-Eugen Hauptmann

Showing 1-14 of 14 articles

Use of a balloon-expandable transfemoral sheath in a TAVI cohort with complex access site - a propensity score matched analysis

Sedaghat A, von Dobbeler C, Sontag B, Sinning J, Fimmers R, Mellert F, Schiller W, Welz A, Grube E, Nickenig G, Hauptmann K-E, Werner N

October 20, 2015 | 10.4244/EIJY15M01_10

Outcome of patients after emergency conversion from transcatheter aortic valve implantation to surgery

Hein R, Abdel-Wahab M, Sievert H, Kuck K, Voehringer M, Hambrecht R, Sack S, Hauptmann K-E, Senges J, Zahn R, Mudra H

August 23, 2013 | 10.4244/EIJV9I4A73

Age-related differences in diagnosis, treatment and outcome of acute coronary syndromes: results from the German ALKK registry

Rittger H, Hochadel M, Behrens S, Hauptmann K-E, Zahn R, Mudra H, Brachmann J, Senges J, Zeymer U

February 21, 2012 | 10.4244/EIJV7I10A191

Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions

Verheye S, Ramcharitar S, Grube E, Schofer J, Witzenbichler B, Kovac J, Hauptmann K-E, Agostoni P, Wiemer M, Lefèvre T, Spaargaren R, Serruys P, Garcia-Garcia H, van Geuns R

September 30, 2011 | 10.4244/EIJV7I5A94

Assessment of the safety and performance of the STENTYS self-expanding coronary stent in acute myocardial infarction: results from the APPOSITION I study

Amoroso G, van Geuns R, Spaulding C, Manzo-Silberman S, Hauptmann K-E, Spaargaren R, Garcia-Garcia H, Serruys P, Verheye S

August 30, 2011 | 10.4244/EIJV7I4A71

Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study

Fajadet J, Wijns W, Laarman GJ, Kuck K, Ormiston J, Baldus S, Hauptmann K-E, Suttorp MJ, Drzewiecki J, Pieper M, Schultheiss H-P, Mauri L

November 15, 2010

Short and long term comparison (24 months) of an alternative sirolimus-coated stent with bioabsorbable polymer and a bare metal stent of similar design in chronic coronary occlusions: the CORACTO trial

Reifart N, Hauptmann K-E, Rabe A, Enayat D, Giokoglu K

August 15, 2010

Contemporary success and complication rates of percutaneous coronary intervention for chronic total coronary occlusions: results from the ALKK quality control registry of 2006

Werner G, Hochadel M, Zeymer U, Kerber S, Schumacher B, Grube E, Hauptmann K-E, Brueck M, Zahn R, Senges J

August 15, 2010

First-in-man (FIM) study of the Stentys™ bifurcation stent – 30 days results

Verheye S, Grube E, Ramcharitar S, Schofer J, Witzenbichler B, Kovac J, Hauptmann K-E, Agostoni P, Wiemer M, Lefèvre T, Serruys P, van Geuns R

March 20, 2009

One year results of a new in situ length-adjustable stent platform with a biodegradable Biolimus A9 eluting polymer: results of the CUSTOM-II trial

Stella P, Mueller R, Pavlakis G, De Bruyne B, Hauptmann K-E, Morice M, Chevalier B, Fajadet J, Sievert H, Grube E

August 20, 2008

Novel drug eluting stent system for customised treatment of coronary lesions: CUSTOM I feasibility trial 24 month results

Grube E, Sievert H, Hauptmann K-E, Mueller R, Gerckens U, Buellesfeld L, Ako J, Shimohama T, Costa M, Fitzgerald P

May 13, 2008

Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents

Dawkins K, Grube E, Guagliumi G, Banning A, Zmudka K, Colombo A, Thuesen L, Hauptmann K-E, Marco J, Wijns W, Popma J, Weissman N, Koglin J, Russell ME

August 20, 2007

Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial

Chevalier B, Serruys P, Silber S, Garcia E, Suryapranata H, Hauptmann K-E, Wijns W, Schuler G, Fath-Ordoubadi F, Worthley S, Thuesen L, Meredith I, Bressers M, Nagai H, Paunovic D

February 20, 2007

Six-month results of a randomized study to evaluate safety and efficacy of a Biolimus A9™ eluting stent with a biodegradable polymer coating

Grube E, Hauptmann K-E, Buellesfeld L, Lim V, Abizaid A

May 20, 2005

1

Latest news

Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…

Hinge point-based aortic annular plane

September 18, 2020

Ahead of print: Histopathology of embolic debris during TAVI

September 18, 2020

Transcatheter VIV implantation for failed surgical bioprostheses

September 18, 2020

VOYAGER PAD, PARTNER 2A, ISCHEMIA and much more

(The Trials book is supported by Biotronik)

August 28, 2020

Over 10,000 followers

September 18, 2020

Steady-state hyperaemia: many routes, one goal

September 18, 2020

This Week's JAA's: Leaflex study, Coronary access after REDO-TAVI...

September 15, 2020

Valvular disease